Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jonathan Lewis currently holds 744,145 shares of ZIOPHARM ONCOLOGY INC (ZIOP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Lewis has been a net buyer of ZIOP stock. They have purchased $18.9K and sold $0 worth of shares.
Jonathan Lewis's most recent insider trade was on Dec 30, 2014, when they sold 34,261 shares at $5.03 per share.
Jonathan Lewis serves as Executive at ZIOPHARM ONCOLOGY INC (ZIOP). They have executed 22 insider transactions totaling $18.9K over their tenure at the company.
Jonathan Lewis holds the position of Executive at ZIOPHARM ONCOLOGY INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Jonathan Lewis has shown a buying trading pattern, with $18.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jonathan Lewis was on Sep 23, 2010, when they sold $509.0K worth of ZIOP shares. This transaction involved 128,850 shares at $3.95 per share.
Jonathan Lewis currently owns 744,145 shares of ZIOPHARM ONCOLOGY INC (ZIOP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jonathan Lewis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jonathan Lewis has 22 Form 4 filings on record as an insider at ZIOPHARM ONCOLOGY INC.
Set alerts for Jonathan Lewis and 40,000+ other insiders.